BridgeMD
Tests treatment safety and results for Non Metastatic Breast Cancer
Official title Efficacy of the MAEva Program (Meditation, Acceptance, and Commitment to Values) Among Patients Treated For Breast Cancer.
ClinicalTrials.gov ID: NCT07326800
What this study is testing
- What it's testing
- The MAEva program combines Acceptance and Committment Therapy (ACT) and mindfulness practices. It is an open and circular intervention, in three sessions (Mindfulness, Acceptance, and Commitment to values).
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, women only
You may be able to join if
- Patients with non-metastatic breast cancer,
- Patients who are able and willing to follow all study procedures in accordance with the protocol,
- Patients who have understood, signed, and dated the consent form,
- Patients who are affiliated with the social security system,
- Patients who are able to remain seated during the 1.5-hour sessions.
You likely can't join if
- Patients with metastatic cancer,
- Presence of an acute psychiatric disorder: acute depression, unstable bipolar disorder, psychotic disorder (delusions, hallucinations), etc.
- Presence of recurrent uncontrolled panic attacks (particularly related to hypochondriacal concerns),
- Insufficient attentional resources for meditation: major attention, memory, or reasoning disorders,
- Presence of cognitive and neurocognitive disorders and deficits,
- Presence of deafness,
See the full eligibility criteria
- Patients with non-metastatic breast cancer,
- Patients who are able and willing to follow all study procedures in accordance with the protocol,
- Patients who have understood, signed, and dated the consent form,
- Patients who are affiliated with the social security system,
- Patients who are able to remain seated during the 1.5-hour sessions.
- Patients with metastatic cancer,
- Presence of an acute psychiatric disorder: acute depression, unstable bipolar disorder, psychotic disorder (delusions, hallucinations), etc.
- Presence of recurrent uncontrolled panic attacks (particularly related to hypochondriacal concerns),
- Insufficient attentional resources for meditation: major attention, memory, or reasoning disorders,
- Presence of cognitive and neurocognitive disorders and deficits,
- Presence of deafness,
- Current participation in another mindfulness program,
- Persons deprived of their liberty or under guardianship (including curatorship),
- Inability to undergo medical monitoring for the trial for geographical, social, or psychological reasons.
The study team makes the final eligibility decision.
Where it's taking place
- Vandœuvre-lès-Nancy, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Vandœuvre-lès-Nancy, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.